Article
Therapeutic Margins in a Novel Preclinical Model of Retinitis Pigmentosa
14 Aug 2013
Abstract excerpt
The third-most common cause of autosomal recessive retinitis pigmentosa (RP) is due to defective cGMP phosphodiesterase-6 (PDE6). Previous work using viral gene therapy on PDE6-mutant mouse models demonstrated photoreceptors can be rescued if administered before degeneration. However, whether visual function can be rescued after degeneration onset has not been addressed. This is a clinically important question,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
